LCD/NCD Portal

NCD50.5

 

OXYGEN TREATMENT OF INNER EAR/CARBON THERAPY

 

Effective Date of this Version

8/1/1978

 

Benefit Category

• Physicians' Services.

• Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

 

Indications and Limitations of Coverage

• Oxygen (95 percent) and carbon dioxide (5 percent) inhalation therapy for inner ear disease, such as endolymphatic hydrops and fluctuant hearing loss, is not reasonable and necessary.

• The therapeutic benefit deriving from this procedure is highly questionable.

 

Medicare NCD Link